Multicenter Phase II Study of Belinostat (PXD101) in Previously Chemotherapy Treated Thymoma and Thymic Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Belinostat (Primary)
- Indications Malignant thymoma; Thymoma
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 May 2015 Data from 74 patients across this and 3 other trials (see CT profiles 54727, 48385 and 219237) were presented at the 2015 American Society of Clinical Oncology annual meeting.
- 10 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.